VANTAGE CONSULTING GROUP INC – Vertex Pharmaceuticals Incorporated Transaction History
VANTAGE CONSULTING GROUP INC portfolio value:
$253,000
portfolio value
VANTAGE CONSULTING GROUP INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.41% | -70 shares | -13K | $289.54 | 875 |
| Q2 2022 | share | Decrease | -2.78% | -27 shares | 12K | $281.79 | 945 |
| Q1 2022 | share | Decrease | -22.36% | -280 shares | -21K | $260.97 | 972 |
| Q4 2021 | share | Decrease | -3.10% | -40 shares | 41K | $222.45 | 1.25K |
| Q3 2021 | share | Increase | +9.77% | 115 shares | -3K | $181.39 | 1.29K |
| Q2 2021 | share | Increase | 0.00% | 1.17K shares | 237K | $201.63 | 1.17K |
| Q1 2021 | share | Decrease | -100.00% | -322 shares | -76K | $214.89 | 0 |
| Q4 2020 | share | Increase | 0.00% | 322 shares | 76K | $236.34 | 322 |